Roth MKM Initiates Coverage On Forian with Buy Rating, Announces Price Target of $5
$FORA
EDP Services
Technology
Roth MKM analyst Richard Baldry initiates coverage on Forian (NASDAQ:FORA) with a Buy rating and announces Price Target of $5.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/20/2023 | $5.00 | Buy | ROTH MKM |
| 4/8/2022 | $9.00 | Buy | Lake Street |
| 3/11/2022 | $35.00 → $32.00 | Outperform | RBC Capital |
| 11/11/2021 | $34.00 → $35.00 | Outperform | RBC Capital |
| 7/9/2021 | $31.00 | Outperform | RBC Capital |
SC 13G/A - Forian Inc. (0001829280) (Subject)
SC 13G/A - Forian Inc. (0001829280) (Subject)
SC 13G - Forian Inc. (0001829280) (Subject)
10-Q - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
ROTH MKM initiated coverage of Forian with a rating of Buy and set a new price target of $5.00
Lake Street initiated coverage of Forian with a rating of Buy and set a new price target of $9.00
RBC Capital reiterated coverage of VerticalScope Holdings with a rating of Outperform and set a new price target of $32.00 from $35.00 previously
NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa. Forian Inc. (NASDAQ:FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. "While this quarter's revenue remained steady, our team's commitment to driving long-term value has resulted in progress in our strategic vision. The addition of Kyber Data Science enhances the momentum we are building to position us well to capitalize on emerging opportunities and deliver sustained success for our stakeholders," stated Max Wygod, Chairman and Chief Executive Officer of Foria
NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/rj92ayah. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call pr
NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC ("Kyber"), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian's position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services. Kyber has established a leading reputation for its inno
4 - Forian Inc. (0001829280) (Issuer)
NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa. Forian Inc. (NASDAQ:FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. "While this quarter's revenue remained steady, our team's commitment to driving long-term value has resulted in progress in our strategic vision. The addition of Kyber Data Science enhances the momentum we are building to position us well to capitalize on emerging opportunities and deliver sustained success for our stakeholders," stated Max Wygod, Chairman and Chief Executive Officer of Foria
NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, and Mike Vesey, Chief Financial Officer, will attend ROTH MKM's 13th annual Technology Event, which will be held on November 19th – 20th, 2024, at the Hard Rock Hotel in New York City. This year's event will consist of 1-on-1 / small group meetings with over 70 innovative growth companies spanning the technology landscape. The format will provide investors with the opportunity to hear from and meet executive management from public and pre-public companies across various Technology sub-sectors. Each meeting will consist of a 40-minute se
NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/rj92ayah. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call pr
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
NEWTOWN, Pa., Sept. 1, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following: Convertible Notes Offering The Company has entered into a convertible note purchase agreement (the "Note Purchase Agreement") with a select group of institutional and accredited investors pursuant to which the Company will issue $24,000,000 aggregate principal amount at 100% of par value of its 3.5% convertible notes due 2025 (the "Notes"). The Notes are convertib
Forian (NASDAQ:FORA) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 50 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $4.88 million which missed the analyst consensus estimate of $5.11 million by 4.56 percent. This is a 0.14 percent increase over sales of $4.87 million the same period last year.
Roth MKM analyst Richard Baldry reiterates Forian (NASDAQ:FORA) with a Buy and maintains $5 price target.
Forian (NASDAQ:FORA) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Forian beat estimated earnings by 67.0%, reporting an EPS of $-0.01 versus an estimate of $-0.03. Revenue was down $2.54 million from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.19 which was followed by a 8.0% increase in the share price the next day. Here's a look at Forian's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate -0.03 -0.05 -0.11 -0.15 EPS Actual 0.16 -0.03 -0.08 -0.11 Revenue Estimate 5.22M 5.10M 5.70M 7.10M Revenue Actual 5.35M 4.8